Tissue-engineered blood vessels with endothelial nitric oxide synthase activity

Hyun Lim Sang, Seung Woo Cho, Jong Chul Park, Oju Jeon, Min Lim Jae, Sang Soo Kim, Byung Soo Kim

Research output: Contribution to journalArticle

31 Citations (Scopus)

Abstract

Nondegradable synthetic polymer vascular grafts used in cardiovascular surgery have shown serious shortcomings, including thrombosis, calcification, infection, and lack of growth potential. Tissue engineering of vascular grafts with autologous stem cells and biodegradable polymeric materials could solve these problems. The present study is aimed to develop a tissue-engineered vascular graft (TEVG) with functional endothelium using autologous bone marrow-derived cells (BMCs) and a hybrid biodegradable polymer scaffold. Hybrid biodegradable polymer scaffolds were fabricated from poly(lactide-co-ε- caprolactone) (PLCL) copolymer reinforced with poly(glycolic acid) (PGA) fibers. Canine bone marrow mononuclear cells were induced in vitro to differentiate into vascular smooth muscle cells and endothelial cells. TEVGs (internal diameter: 10 mm, length: 40 mm) were fabricated by seeding vascular cells differentiated from BMCs onto PGA/PLCL scaffolds and implanted into the abdominal aorta of bone marrow donor dogs (n = 7). Eight weeks after implantation of the TEVGs, the vascular grafts remained patent. Histological and immunohistochemical analyses of the vascular grafts retrieved at 8 weeks revealed the regeneration of endothelium and smooth muscle and the presence of collagen. Western blot analysis showed that endothelial nitric oxide synthase (eNOS) was expressed in TEVGs comparable to native abdominal aortas. This study demonstrates that vascular grafts with significant eNOS activity can be tissue-engineered with autologous BMCs and hybrid biodegradable polymer scaffolds.

Original languageEnglish
Pages (from-to)537-546
Number of pages10
JournalJournal of Biomedical Materials Research - Part B Applied Biomaterials
Volume85
Issue number2
DOIs
Publication statusPublished - 2008 May 1

Fingerprint

Nitric Oxide Synthase Type III
Nitric oxide
Blood vessels
Grafts
Tissue
Bone
Scaffolds
Biodegradable polymers
Prostaglandins A
glycolic acid
Muscle
Cardiovascular surgery
Bioelectric potentials
Endothelial cells
Polymers
Stem cells
Tissue engineering
Collagen
Copolymers
Cells

All Science Journal Classification (ASJC) codes

  • Biomaterials
  • Biomedical Engineering

Cite this

@article{d64a31d036bf48e7b5a37b87d7834965,
title = "Tissue-engineered blood vessels with endothelial nitric oxide synthase activity",
abstract = "Nondegradable synthetic polymer vascular grafts used in cardiovascular surgery have shown serious shortcomings, including thrombosis, calcification, infection, and lack of growth potential. Tissue engineering of vascular grafts with autologous stem cells and biodegradable polymeric materials could solve these problems. The present study is aimed to develop a tissue-engineered vascular graft (TEVG) with functional endothelium using autologous bone marrow-derived cells (BMCs) and a hybrid biodegradable polymer scaffold. Hybrid biodegradable polymer scaffolds were fabricated from poly(lactide-co-ε- caprolactone) (PLCL) copolymer reinforced with poly(glycolic acid) (PGA) fibers. Canine bone marrow mononuclear cells were induced in vitro to differentiate into vascular smooth muscle cells and endothelial cells. TEVGs (internal diameter: 10 mm, length: 40 mm) were fabricated by seeding vascular cells differentiated from BMCs onto PGA/PLCL scaffolds and implanted into the abdominal aorta of bone marrow donor dogs (n = 7). Eight weeks after implantation of the TEVGs, the vascular grafts remained patent. Histological and immunohistochemical analyses of the vascular grafts retrieved at 8 weeks revealed the regeneration of endothelium and smooth muscle and the presence of collagen. Western blot analysis showed that endothelial nitric oxide synthase (eNOS) was expressed in TEVGs comparable to native abdominal aortas. This study demonstrates that vascular grafts with significant eNOS activity can be tissue-engineered with autologous BMCs and hybrid biodegradable polymer scaffolds.",
author = "Sang, {Hyun Lim} and Cho, {Seung Woo} and Park, {Jong Chul} and Oju Jeon and Jae, {Min Lim} and Kim, {Sang Soo} and Kim, {Byung Soo}",
year = "2008",
month = "5",
day = "1",
doi = "10.1002/jbm.b.30977",
language = "English",
volume = "85",
pages = "537--546",
journal = "Journal of Biomedical Materials Research - Part B Applied Biomaterials",
issn = "1552-4973",
number = "2",

}

Tissue-engineered blood vessels with endothelial nitric oxide synthase activity. / Sang, Hyun Lim; Cho, Seung Woo; Park, Jong Chul; Jeon, Oju; Jae, Min Lim; Kim, Sang Soo; Kim, Byung Soo.

In: Journal of Biomedical Materials Research - Part B Applied Biomaterials, Vol. 85, No. 2, 01.05.2008, p. 537-546.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Tissue-engineered blood vessels with endothelial nitric oxide synthase activity

AU - Sang, Hyun Lim

AU - Cho, Seung Woo

AU - Park, Jong Chul

AU - Jeon, Oju

AU - Jae, Min Lim

AU - Kim, Sang Soo

AU - Kim, Byung Soo

PY - 2008/5/1

Y1 - 2008/5/1

N2 - Nondegradable synthetic polymer vascular grafts used in cardiovascular surgery have shown serious shortcomings, including thrombosis, calcification, infection, and lack of growth potential. Tissue engineering of vascular grafts with autologous stem cells and biodegradable polymeric materials could solve these problems. The present study is aimed to develop a tissue-engineered vascular graft (TEVG) with functional endothelium using autologous bone marrow-derived cells (BMCs) and a hybrid biodegradable polymer scaffold. Hybrid biodegradable polymer scaffolds were fabricated from poly(lactide-co-ε- caprolactone) (PLCL) copolymer reinforced with poly(glycolic acid) (PGA) fibers. Canine bone marrow mononuclear cells were induced in vitro to differentiate into vascular smooth muscle cells and endothelial cells. TEVGs (internal diameter: 10 mm, length: 40 mm) were fabricated by seeding vascular cells differentiated from BMCs onto PGA/PLCL scaffolds and implanted into the abdominal aorta of bone marrow donor dogs (n = 7). Eight weeks after implantation of the TEVGs, the vascular grafts remained patent. Histological and immunohistochemical analyses of the vascular grafts retrieved at 8 weeks revealed the regeneration of endothelium and smooth muscle and the presence of collagen. Western blot analysis showed that endothelial nitric oxide synthase (eNOS) was expressed in TEVGs comparable to native abdominal aortas. This study demonstrates that vascular grafts with significant eNOS activity can be tissue-engineered with autologous BMCs and hybrid biodegradable polymer scaffolds.

AB - Nondegradable synthetic polymer vascular grafts used in cardiovascular surgery have shown serious shortcomings, including thrombosis, calcification, infection, and lack of growth potential. Tissue engineering of vascular grafts with autologous stem cells and biodegradable polymeric materials could solve these problems. The present study is aimed to develop a tissue-engineered vascular graft (TEVG) with functional endothelium using autologous bone marrow-derived cells (BMCs) and a hybrid biodegradable polymer scaffold. Hybrid biodegradable polymer scaffolds were fabricated from poly(lactide-co-ε- caprolactone) (PLCL) copolymer reinforced with poly(glycolic acid) (PGA) fibers. Canine bone marrow mononuclear cells were induced in vitro to differentiate into vascular smooth muscle cells and endothelial cells. TEVGs (internal diameter: 10 mm, length: 40 mm) were fabricated by seeding vascular cells differentiated from BMCs onto PGA/PLCL scaffolds and implanted into the abdominal aorta of bone marrow donor dogs (n = 7). Eight weeks after implantation of the TEVGs, the vascular grafts remained patent. Histological and immunohistochemical analyses of the vascular grafts retrieved at 8 weeks revealed the regeneration of endothelium and smooth muscle and the presence of collagen. Western blot analysis showed that endothelial nitric oxide synthase (eNOS) was expressed in TEVGs comparable to native abdominal aortas. This study demonstrates that vascular grafts with significant eNOS activity can be tissue-engineered with autologous BMCs and hybrid biodegradable polymer scaffolds.

UR - http://www.scopus.com/inward/record.url?scp=42649098262&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=42649098262&partnerID=8YFLogxK

U2 - 10.1002/jbm.b.30977

DO - 10.1002/jbm.b.30977

M3 - Article

C2 - 18076094

AN - SCOPUS:42649098262

VL - 85

SP - 537

EP - 546

JO - Journal of Biomedical Materials Research - Part B Applied Biomaterials

JF - Journal of Biomedical Materials Research - Part B Applied Biomaterials

SN - 1552-4973

IS - 2

ER -